Pharma

Your Article Summary

See Latest Articles

Cytokinetics to Hold a Conference Call Tuesday, May 2009 to Discuss its Collaboration and Option Agreement with Amgen
Cytokinetics, 05/27/09

Cytokinetics, Incorporated is scheduled to hold a conference call on Tuesday, May 2009 to discuss its Collaboration and Option Agreement with Amgen relating to its cardiac contractility program that includes CK-1827452, a novel cardiac myosin activator, as a potential treatment for heart failure.

Today in M&A/Partnerships...keeping you current

Receive free subspecialty "5-minute updates" via email

Inno Biologics and CEVEC Sign License Agreement for Human CAP Technology
b3c newswire, 12/09/09

Federal Advisory Committees to Meet
HealthDataManagement, 12/09/09

Mylan Announces Settlement Agreement Related to Antidepressant Effexor XR
Mylan, 12/09/09

 See all of M&A/Partnerships